We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Smart Microgel Could Repair and Replace Damaged Organs

By HospiMedica International staff writers
Posted on 23 Jun 2025

Repairing or replacing damaged organs remains a central challenge in regenerative medicine, where delivering therapeutic cells or creating viable tissue structures often requires delicate, controlled environments. More...

Conventional microgel production methods frequently rely on harsh chemicals or multi-step recovery processes that can damage living cells or introduce contaminants. Researchers have now developed a new microfluidics tool that generates 'smart' microgel droplets capable of supporting sensitive biomedical applications without compromising safety or functionality.

The new microfluidics tool named UQ-Surf was developed by researchers from the University of Queensland (Brisbane, QLD, Australia) and focuses on regenerative medicine. UQ-Surf is designed to produce high volumes of uniform, biocompatible microgel droplets at remarkable speed and precision. The UQ-Surf tool can generate thousands of microdroplets per minute, each acting as a temperature-responsive environment ideal for cell therapies and tissue engineering. Unlike conventional systems, the microgels produced with UQ-Surf do not require harmful chemical demulsifiers or post-processing treatments to isolate the encapsulated materials. This eliminates the risk of contamination and preserves the biological integrity of the contents. The platform's core innovation lies in its ability to encapsulate living materials without exposing them to toxic agents, making the droplets safe for clinical and translational applications.

The UQ-Surf platform has already been patented and implemented in laboratory settings, demonstrating its readiness for broader use. Its output of chemically stable and biologically compatible microgels positions it as a practical tool for diverse biomedical tasks, from drug delivery to developing in vitro 3D models for therapeutic testing. By simplifying microgel production and avoiding cytotoxic processing steps, UQ-Surf offers a scalable, contamination-free alternative for regenerative medicine research. Its compatibility with living cells and high-throughput capacity make it especially promising for targeted delivery systems, gene therapies, and the future of engineered tissues. The platform’s temperature-sensitive and modular nature further supports its adaptability across a wide range of therapeutic areas.

Related Links:
University of Queensland


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
New
Steam Sterilizer
AMSCO 400 Series
New
Short Phlebotomy Cart
MSWA-3469-WHT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: For the first time, a fluorescent-guided nerve imaging agent has shown promise for use in humans (Photo courtesy of VUMC)

Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery

Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.